Figure 5: Resistance patterns to antibiotics in patients with HAUTIs from the GPIU study 2003–2013; left: prevalence of multidrug resistance (MDR) microorganisms; right: resistance rates for the main groups of antibiotics [29]; MDR: multidrug resistance, MAGI: male accessory gland infection, ASB: asymptomatic bacteriuria, Cefta: ceftriaxone, Cipro: ciprofloxacin, Genta: gentamicin, TMP/SMX: trimethoprim-sulfamethoxazole, Pip/Tzb: piperacillin/tazobactam